Showing 191-200 of 377 results for "".
- Performance Beauty Company Submits Premarket Approval Application for Dermal Filler Productshttps://modernaesthetics.com/news/performance-beauty-company-submits-premarket-approval-application-for-dermal-filler-products/2473607/Evolus, Inc. submitted the final module of its permarket approval (PMA) application to the US Food and Drug Administration for dermal filler products. Evolysse Lift and Evolysse Smooth dermal fillers are for the nasolabial fold (NLF). Evolus expects the FDA’s
- New cream targeting redness-prone skin hits markethttps://modernaesthetics.com/news/new-cream-targeting-redness-prone-skin-hits-market/2473597/Eau Thermale Avene launched its latest innovative treatment for redness-prone skin on Tuesday. The NEW! Avene Redness Expert Soothing Moisturizing Concentrated Cream targets sensitive, reactive, or intolerant skin that’s prone to redness. The cream is lightwe
- Natural alternative for Salicylic Acid to manage skin, acne care introducedhttps://modernaesthetics.com/news/new-alternative-salicylic-acid-manage-skin-acne-care-introduced/2473586/A more natural way to manage skin and acne care is entering the market. Active Concepts introduced ACB Sal-Vation as an alternative to salicylic acid. It’s made up of benzoic acid, naturally found in prunes, and succinic acid, naturally found in sugar beets.
- Alma Introduces Alma IQ With World's Most Versatile Aesthetic Workstationhttps://modernaesthetics.com/news/alma-advances-personalization-worlds-most-versatile-aesthetic-workstation-intelligence-skin-analysis-system/2473584/Alma IQ is a custom skin analysis system built to redefine and elevate the patient experience. It’s the latest innovation debuted from Alma, a global leader in energy-based medical and aesthetics solutions. The system has smart technology with 10 light mode, scanning multiple skin
- FDA Clears New Indication for UltraClear Laserhttps://modernaesthetics.com/news/fda-clears-new-indication-for-ultraclear-laser/2473577/The U.S. Food and Drug Administration (FDA) cleared a new indication of Acclaro Medical's UltraClear® cold ablative fractional 2910 nm fiber laser, expanding the use of the technology for the treatment of benign pigmented lesions and vascular dyschromia, the company announced i
- Glamour Ranks Best Face Moisturizershttps://modernaesthetics.com/news/glamour-ranks-best-face-moisturizers/2473574/Glamour released its “22 Best Face Moisturizers” list, naming SkinMedica’s HA5 Rejuvenating Hydrator the best overall. “I think my skin actually looks different—in a good way,” one tester said of the SkinMedica product. The monthslong process
- Aesthetic Society Names New Presidenthttps://modernaesthetics.com/news/aesthetic-society-names-new-president/2473569/The Aesthetic Society announced the appointment of Kiya Movassaghi, MD, DMD, FACS, a board-certified plastic surgeon from Eugene, Oregon, as its president, saying his leadership will focus on strategically fortifying The Society's position as the global leader in education and innov
- BIOCORNEUM Joins Bioderma Portfoliohttps://modernaesthetics.com/news/biocorneum-joins-bioderma-portfolio/2473567/Nuance Medical announced the successful acquisition of BIOCORNEUM, a silicone gel scar treatment brand previously owned by Sientra, according to a press release. Effective immediately, BIOCORNEUM will become a part of the Biodermis portfolio, Nuance Medical’s brand specializing in silicone
- Murad Alam, MD, FAAD, Elected American Academy of Dermatology President for 2026https://modernaesthetics.com/news/murad-alam-md-faad-elected-american-academy-of-dermatology-president-for-2026/2473558/Chicago-based board-certified dermatologist Murad Alam, MD, FAAD, has been elected to lead the American Academy of Dermatology (AAD). He will be installed as president-elect in March 2025 and hold the office of president for 1 year beginning in March 2026. AAD is the world’s large
- Letybo (letibotulinumtoxinA-wlbg) Receives FDA Approvalhttps://modernaesthetics.com/news/fda-grants-approval-for-letybo-letibotulinumtoxina-wlbg/2473551/Hugel America, Inc., announced the achievement of a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for its neurotoxin, Letybo. "We are thrilled with the FDA's approval of Letybo. This is a huge achievement for Hugel as we